Leo Zacharski, M.D., and Robert G. Lerner, M.D.
Dr. Zacharski is Professor of Medicine, Dartmouth Medical School, Hanover, New Hampshire, and Associate Chief of Staff, VA Medical Center, White River Junction, Vermont.
In the past three years, Dr. Zacharski has received support from the Department of Veterans Affairs Medical Research Service, and has been on the Speakers' Bureau for Dupont Pharmaceutical and Aventis. In the past three years, Dr. Lerner has served as a consultant for RPR, and has served on the Speakers' Bureau for Pharmacia & Upjohn.
Release Date: 11/21/2000
Upon completion of this Cyberounds®, you should be able to:
Describe "warfarin resistant" DVT in cancer patients
Describe several mechanisms by which heparin could alter tumor progression
Evaluate, critically, new data on the effect of heparin and LMWH on cancer.
